MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202218066775 A) filed by Viacyte, Inc, San Diego, on Nov. 21, 2022, for 'pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof.'
Inventor(s) include D'Amour, Kevin, Allen; Kroon, Evert; Scott, Michael; Martinson, Laura; and Mcgreevy, Craig.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "Disclosed are devices and methods for transplanting cells, such as pancreatic endoderm cells, into a host. The devices include a non-woven fabric external to a cell-excluding membrane, and the non-woven fabric and/or cell-excluding membrane can be perforated. Treatment of the host with immunosuppressive reagents, required to inhibit allograft rejection due to perforations in the cell delivery device, does not compromise maturation or function of transplanted pancreatic endoderm cells."
The patent application was internationally filed on Nov. 10, 2016, under International application No.PCT/US2016/061442.
Disclaimer: Curated by HT Syndication.
